Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic nephropathy

S M Kobrin1

  • 1Inpatient Dialysis Program, University of Pennsylvania, USA.

Disease-A-Month : DM
|July 10, 1998
PubMed
Summary
This summary is machine-generated.

Diabetic nephropathy, a leading cause of end-stage renal disease (ESRD), can be slowed by managing blood sugar and pressure. Early interventions improve quality of life and reduce healthcare costs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delayed function reduces renal allograft survival independent of acute rejection.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1996
Same author

Reversal of acute renal allograft rejection by extracorporeal photopheresis: a case presentation and review of the literature.

Journal of clinical apheresis·1996
Same author

Behavioral and biochemical indices of compliance in hemodialysis patients.

ASAIO transactions·1991
Same author

Magnesium deficiency.

Seminars in nephrology·1990
Same author

Variable efficacy of calcium carbonate tablets.

American journal of kidney diseases : the official journal of the National Kidney Foundation·1989
Same author

Effect of varying dialysate bicarbonate concentration on serum phosphate.

ASAIO transactions·1989
Same journal

Disturbances due to cold.

Disease-a-month : DM·2026
Same journal

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

Disease-a-month : DM·2026
Same journal

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Disease-a-month : DM·2026
Same journal

Periodontal disease and diabetic kidney disease: A comprehensive analysis.

Disease-a-month : DM·2026
Same journal

Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits.

Disease-a-month : DM·2026
Same journal

Foreword for insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

Disease-a-month : DM·2026
See all related articles

Area of Science:

  • Nephrology
  • Endocrinology
  • Public Health

Background:

  • Diabetic nephropathy is the primary cause of end-stage renal disease (ESRD), affecting 35% of US ESRD patients.
  • Managing diabetic nephropathy incurs significant costs, averaging $50,000 annually per patient.
  • The increasing prevalence of diabetes mellitus necessitates effective strategies to manage diabetic nephropathy.

Purpose of the Study:

  • To review therapeutic interventions for delaying diabetic nephropathy progression.
  • To highlight the role of primary care physicians in managing diabetic nephropathy.
  • To discuss strategies for improving patient quality of life and reducing healthcare expenditures.

Main Methods:

  • Review of current medical literature on diabetic nephropathy management.

Related Experiment Videos

  • Focus on therapeutic interventions including euglycemia, blood pressure control, and ACE inhibitors.
  • Discussion of lifestyle modifications and renal replacement therapy.

    • Main Results:

    • Advances in management allow for intervention to retard renal failure progression.
    • Optimal blood pressure control and euglycemia are crucial.
    • Angiotensin-converting enzyme inhibitors offer renal-protective benefits.

    Conclusions:

    • Therapeutic interventions can significantly delay the progression of diabetic nephropathy.
    • Lifestyle modifications like low-protein diet, cholesterol management, and smoking cessation are beneficial.
    • Timely consideration of dialysis and transplantation is essential for patient outcomes.